Harnessing immunoinformatics for the rational design of mRNA vaccines against the emerging Junin virus
In Silico Pharmacology · 01.04.2026 · 14 (1)
DOI: 10.1007/s40203-026-00587-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Silico Pharmacology, online erschienen am 01.04.2026. Verfasst von Elijah Kolawole Oladipo und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Genome and Molecular Sciences, Helix Biogen Institute, Ogbomoso, Oyo State Nigeria. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Junin virus (JUNV) is a zoonotic virus and is the main cause of Argentine hemorrhagic fever (AHF). Despite the availability of the Candid#1 live-attenuated vaccine, safety concerns and limited accessibility necessitate the development of a safer, more effective alternative. This study employed computational and bioinformatics approaches to design a multi-epitope mRNA vaccine targeting JUNV glycoproteins. Antigenic glycoprotein sequences were retrieved and screened for Linear B-cell (LBL), cytotoxic T-cell (CTL), and helper T-cell (HTL) epitopes, ensuring high antigenicity, non-toxicity, and non-allergenicity. Eight B-cell, fifteen CTL, and five HTL epitopes were selected based on high antigenicity, non-allergenicity, and non-toxicity. Population coverage analysis revealed an 88.19% global coverage, suggesting broad vaccine applicability. The designed vaccine constructs incorporated immunogenic linkers and 50S ribosomal protein L7/L12 as an adjuvant to enhance immune activation. Physicochemical and post-translational modification analyses confirmed the stability, structural integrity, and immunogenic potential of the constructs. Molecular docking and molecular dynamics (MD) simulations demonstrated strong and stable interactions with TLR4, MHCI, MHCII, and CTL2 receptors, essential for effective immune stimulation. Codon optimization and mRNA secondary structure analysis ensured efficient expression and stability in human cells. Finally, in silico immune simulation predicted robust humoral and cellular immune responses, characterized by high IgG and IgM titers, cytokine production (IFN-γ, IL-4, IL-10), and memory B-cell activation, confirming long-term immunity. These findings highlight the potential of the designed mRNA vaccine for effective JUNV immunization, warranting further in vitro and in vivo validation for clinical application.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Genome and Molecular Sciences, Helix Biogen Institute, Ogbomoso, Oyo State Nigeria.
- Division of Vaccine and Pharmacotherapies Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State Nigeria.
- Division of Diagnostic Assay Development and Medical Artificial Intelligence, Helix Biogen Institute, Ogbomoso, Oyo State Nigeria.
- Division of Experimental Animal Resources Division, Helix Biogen Institute, Ogbomoso, Oyo State Nigeria.
- Department of Molecular Biology, Immunology and Bioinformatics, Adeleke University, Ede, Osun State Nigeria.
- Department of Physiology, Ladoke Akintola University of Technology, Ogbomoso, Oyo State Nigeria.
Zitieren
APA
Oladipo, E. K., Irewolede, B. A., Aderibigbe, K. A., Hammed, O. S., Jegede, A. J., Opeyemi, O. H., Adaeze, C. J., Adedotun, O. J., Adebola, A. M., Dorcas, A. O., Adebola, A. K., Kolawole, O. V., Olamide, O. R., Olamiposi, K. P., Olatunde, S. K., Jimah, E. M., Awoyelu, E. H., Oloke, J. K., Kolawole, O. M., & Iwalokun, B. A. (2026). Harnessing immunoinformatics for the rational design of mRNA vaccines against the emerging Junin virus. In Silico Pharmacology, 14(1). https://doi.org/10.1007/s40203-026-00587-7
Vancouver
Oladipo EK, Irewolede BA, Aderibigbe KA, Hammed OS, Jegede AJ, Opeyemi OH, et al. Harnessing immunoinformatics for the rational design of mRNA vaccines against the emerging Junin virus. In Silico Pharmacology. 2026;14(1). doi:10.1007/s40203-026-00587-7
BibTeX
@article{Oladipo2026,
author = {Oladipo, Elijah Kolawole and Irewolede, Boluwatife Ayobami and Aderibigbe, Kehinde Abolade and Hammed, Opeyemi Sodiq and Jegede, Ayomide Jonathan and Opeyemi, Ogundele Hiqmah and Adaeze, Chukwudebelu Jessica and Adedotun, Oluwanifemi John and Adebola, Abduljelil Mutiat and Dorcas, Adeyemi Olamide and Adebola, Ahmed Khadijah and Kolawole, Oyekunle Victor and Olamide, Oni Roheemah and Olamiposi, King Precious and Olatunde, Simeon Kayowa and Jimah, Esther Moradeyo and Awoyelu, Elukunbi Hilda and Oloke, Julius Kola and Kolawole, Olatunji Matthew and Iwalokun, Bamidele Abiodun},
title = {Harnessing immunoinformatics for the rational design of mRNA vaccines against the emerging Junin virus},
journal = {In Silico Pharmacology},
year = {2026},
volume = {14},
number = {1},
doi = {10.1007/s40203-026-00587-7}
}
EUVIMED